AAP
IRWD icon

Arax Advisory Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Arax Advisory Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.98K Buy
1,703
+1,680
+7,304% +$6.89K ﹤0.01% 2701
2025
Q4 		$78 Sell
23
-143,369
-100% -$372K ﹤0.01% 3865
2025
Q3 		$188K Buy
+143,392
New +$148K ﹤0.01% 1287
2024
Q4 		– Sell
-63
Closed -$260 – 2575
2024
Q3 		$260 Buy
+63
New +$339 ﹤0.01% 2488

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Arax Advisory Partners's IRWD Position: Q1 2026 in Review

Arax Advisory Partners increased its Ironwood Pharmaceuticals (IRWD) stake by 7,304% in Q1 2026, buying an estimated $6.89K and bringing the position to 1,703 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Arax Advisory Partners first reported a position in IRWD in Q3 2024 and has held it in 4 quarters since. The position peaked at $188K in Q3 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Arax Advisory Partners held 1,703 shares of Ironwood Pharmaceuticals worth $5.98K as of Q1 2026.
  • Arax Advisory Partners bought 1,680 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $6.89K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2701 holding.
  • Arax Advisory Partners first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Arax Advisory Partners's Ironwood Pharmaceuticals position peaked at $188K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.